Melphalan and Mycobacterial infection - a phase IV clinical study of FDA data

Summary:

Mycobacterial infection is reported as a side effect among people who take Melphalan (melphalan), especially for people who are male, 10-19 old, also take Tacrolimus, and have Bone marrow conditioning regimen.

The phase IV clinical study analyzes which people have Mycobacterial infection when taking Melphalan. It is created by eHealthMe based on reports of 20,050 people who have side effects when taking Melphalan from the FDA, and is updated regularly.

What is Melphalan?

Melphalan has active ingredients of melphalan. eHealthMe is studying from 20,052 Melphalan users. Check the latest studies of Melphalan.

What is Mycobacterial infection?

Mycobacterial infection is found to be associated with 166 drugs and 311 conditions by eHealthMe. Check the latest studies of Mycobacterial infection.

On Jul, 11, 2026

20,050 people reported to have side effects when taking Melphalan.
Among them, 27 people (0.13%) have Mycobacterial infection.

Could Melphalan cause Mycobacterial infection?

Among these 27 people:

What is the gender of people who have Mycobacterial infection when taking Melphalan? *

female: 4.55 %
male: 95.45 %

What is the age of people who have Mycobacterial infection when taking Melphalan? *

What are other drugs people take besides Melphalan? *

Tacrolimus: 15 people, 55.56%
Mycophenolate Mofetil: 13 people, 48.15%
Cyclosporine: 13 people, 48.15%
Methylprednisolone: 13 people, 48.15%
Ciclosporin: 5 people, 18.52%
Fludarabine Phosphate: 4 people, 14.81%
Voriconazole: 1 person, 3.70%
Azathioprine: 1 person, 3.70%
Bendamustine: 1 person, 3.70%
Cytarabine: 1 person, 3.70%

What are other side effects people have besides Mycobacterial infection? *

Tumor: 16 people, 59.26%
Colitis (inflammation of colon): 8 people, 29.63%
Urinary Tract Infection: 7 people, 25.93%
Bk Virus Infection: 7 people, 25.93%
Fever: 7 people, 25.93%
Abdominal Pain: 5 people, 18.52%
Gallstones (stone formation by bile component): 5 people, 18.52%
Acute Graft Versus Host Disease In Intestine (acute complication in intestine following an allogeneic tissue/blood transplant): 4 people, 14.81%
Acute Graft Versus Host Disease In Liver (acute complication in liver following an allogeneic tissue/blood transplant): 4 people, 14.81%
Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 4 people, 14.81%

What are the existing conditions these people have? *

Bone Marrow Conditioning Regimen: 20 people, 74.07%
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant): 12 people, 44.44%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 7 people, 25.93%
Immunodeficiency Disorders: 3 people, 11.11%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 11.11%
Immune Tolerance Induction: 2 people, 7.41%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.70%
Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 1 person, 3.70%
Acute Graft Versus Host Disease In Liver (acute complication in liver following an allogeneic tissue/blood transplant): 1 person, 3.70%
Acute Graft Versus Host Disease In Intestine (acute complication in intestine following an allogeneic tissue/blood transplant): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Melphalan and have Mycobacterial infection?

- Check whether Mycobacterial infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Melphalan:

Melphalan (20,052 reports)

Browse all side effects of Melphalan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Mycobacterial infection:

Mycobacterial infection (166 drugs)

Browse all the conditions that are associated with Mycobacterial infection:

Mycobacterial infection (311 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on melphalan (the active ingredients of Melphalan) and Melphalan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.